Participation of the CD94 receptor complex in costimulation of human natural killer cells

Journal of Immunology

Volumn 160, Issue 4, 1998, Pages 1618-1626

  Voss, Stephan D ^c   Daley, John ^a,b   Ritz, Jerome ^a,b   Robertson, Michael J ^a,b,d,e  

^a DANA FARBER CANCER INSTITUTE   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^d INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e INDIANA UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD16 ANTIGEN; CD56 ANTIGEN; CD94 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 15; INTERLEUKIN 2;

ANTIGEN EXPRESSION; ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; ISOELECTRIC FOCUSING; LYMPHOCYTE ACTIVATION; LYMPHOCYTE PROLIFERATION; LYMPHOCYTE SUBPOPULATION; NATURAL KILLER CELL; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, CD; ANTIGENS, CD56; ANTIGENS, CD94; CELL COMMUNICATION; CYTOKINES; FEMALE; HUMANS; KILLER CELLS, NATURAL; LECTINS, C-TYPE; LEUKEMIA, ERYTHROBLASTIC, ACUTE; LYMPHOCYTE ACTIVATION; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED BALB C; RECEPTORS, MITOGEN; TUMOR CELLS, CULTURED;

EID: 0032519453     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (56)

1. Trinchieri, G. 1989. Biology of natural killer cells. Adv. Immunol. 47:187.
2. Robertson, M. J., and J. Ritz. 1990. Biology and clinical relevance of human natural killer cells. Blood 76:2421.
3. Anegon, I., M. C. Cuturi, G. Trinchieri, and B. Perussia. 1988. Interaction of Fc receptor (CD16) ligands induces transcription of interleukin 2 receptor (CD25) and lymphokine genes and expression of their products in human natural killer cells. J. Exp. Med. 167:452.
4. Carson, W. E., M. E. Ross, R. A. Baiocchi, M. J. Marien, N. Boiani, K. Grabstein, and M. A. Caligiuri. 1995. Endogenous production of interleukin 15 by activated human monocytes is critical for optimal production of interferon-γ by natural killer cells in vitro. J. Clin. Invest. 96:2578.
5. Hunter, C. A., R. Chizzonite, and J. S. Remington. 1995. IL-1β is required for IL-12 to induce production of IFN-γ by NK cells: a role for IL-1β in the T cell-independent mechanism of resistance against intracellular pathogens. J. Immunol. 155:4347.
6. Paya, C. V., N. Kenmotsu, R. A. Schoon, and P. J. Leibson. 1988. Tumor necrosis factor and lymphotoxin secretion by human natural killer cells leads to antiviral cytotoxicity. J. Immunol. 141:1989.
7. Cuturi, M. C., I. Anegon, F. Sherman, R. Loudon, S. C. Clark, B. Perussia, and G. Trinchieri. 1989. Production of hematopoietic colony-stimulating factors by human natural killer cells. J. Exp. Med. 169:569.
8. Warren, H. S., B. F. Kinnear, J. H. Phillips, and L. L. Lanier. 1995. Production of IL-5 by human NK cells and regulation of IL-5 secretion by IL-4, IL-10, and IL-12. J. Immunol. 154:5144.
9. Kos, F. J., and E. G. Engleman. 1996. Immune regulation: a critical link between NK cells and CTLs. Immunol. Today 17:174.
10. Anderson, P., M. Caligiuri, J. Ritz, and S. F. Schlossman. 1989. CD3 negative natural killer cells express ζ TCR as part of a novel molecular complex. Nature 341:159.
11. Lanier, L. L., G. Yu, and J. H. Phillips. 1989. Co-association of CD3 ζ with a receptor (CD 16) for IgG Fc on human natural killer cells. Nature 342:803.
12. Leibson, P. J. 1995. MHC-recognizing receptors: they're not just for T cells anymore. Immunity 3:5.
13. Raulet, D. H., and W. Held. 1995. Natural killer receptors: the offs and ons of NK cell recognition. Cell 82:697.
14. Gumperz, J. E., and P. Parham. 1995. The enigma of the natural killer cell. Nature 378:245.
15. Lanier, L. L., and J. H. Phillips. 1996. Inhibitory MHC class I receptors on NK cells and T cells. Immunol. Today 17:86.
16. Robertson, M. J., T. J. Manley, C. Donahue, H. Levine, and J. Ritz. 1993. Costimulatory signals are required for optimal proliferation of human natural killer cells. J. Immunol. 150:1705.
17. Robertson, M. J., C. Cameron, S. Lazo, K. J. Cochran, S. D. Voss, and J. Ritz. 1997. Costimulation of human natural killer cell proliferation: role of accessory cytokines and cell contact-dependent signals. Nat. Immun. 15:213.
18. Carson, W. E., J. G. Giri, M. J. Lindemann, M. L. Linett, M. Ahdieh, R. Paxton, D. Anderson, J. Eisenmann, K. Grabstein, and M. A. Caligiuri. 1994. Interleukin (IL) 15 is a novel cytokine that activates human natural killer cells via components of the IL-2 receptor. J. Exp. Med. 180:1395.
19. dim) human NK cells. J. Immunol. 156:3254.
20. Rabinowich, H., P. Sedlmayr, R. B. Herberman, and T. L. Whiteside. 1991. Increased proliferation, lytic activity, and purity of human natural killer cells cocultured with mitogen-activated feeder cells. Cell. Immunol. 135:454.
21. Nandi, D., J. A. Gross, and J. P. Allison. 1994. CD28-mediated costimulation is necessary for optimal proliferation of murine NK cells. J. Immunol. 152:3361.
22. Lanier, L. L., A. M. Le, C. I. Civin, M. R. Loken, and J. H. Phillips. 1986. The relationship of CD16 (Leu-11) and Leu-19 (NKH-1) antigen expression on human peripheral blood NK cells and cytotoxic T lymphocytes. J. Immunol. 136: 4480.
23. Nagler, A., L. L. Lanier, S. Cwirla, and J. H. Phillips. 1989. Comparative studies of human FcR III-positive and negative natural killer cells. J. Immunol. 143:3183.
24. Baume, D. M., M. J. Robertson, H. Levine, T. J. Manley, P. W. Schow, and J. Ritz. 1992. Differential responses to interleukin-2 define functionally distinct subsets of human natural killer cells. Eur. J. Immunol. 22:1.
25. Caligiuri, M. A., A. Zmuidzinas, T. J. Manley, H. Levine, K. A. Smith, and J. Ritz. 1990. Functional consequences of interleukin 2 receptor expression on resting human lymphocytes: identification of a novel natural killer cell subset with high affinity receptors. J. Exp. Med. 171:1509.
26. Robertson, M. J., T. J. Manley, G. Pichert, C. Cameron, K. J. Cochran, H. Levine, and J. Ritz. 1995. Functional consequences of APO-1/Fas (CD95) antigen expression by normal and neoplastic hematopoietic cells. Leukemia Lymphoma 17: 51.
27. + T lymphocytes. I. Inhibition of the IL-2-dependent proliferation by anti-Kp 43 monoclonal antibody. J. Immunol. 144:3238.
28. Sivori, S., M. Vitale, C. Bottino, E. Marcenaro, L. Sanseverino, S. Parolini, L. Moretta, and A. Moretta. 1996. CD94 functions as a natural killer cell inhibitory receptor for different HLA class I alleles: identification of the inhibitory form of CD94 by the use of novel monoclonal antibodies. Eur. J. Immunol. 26:2487.
29. Carretero, M., C. Cantoni, T. Bellon, C. Bottino, R. Biassoni, A. Rodriguez, J. J. Perez-Villar, L. Moretta, A. Moretta, and M. Lopez-Botet. 1997. The CD94 and NKG2-A C-type lectins covalently assemble to form a natural killer cell inhibitory receptor for HLA class I molecules. Eur. J. Immunol. 27:563.
30. Robertson, M. J., R. J. Soiffer, S. F. Wolf, T. J. Manley, C. Donahue, D. Young, S. H. Herrmann, and J. Ritz. 1992. Response of human natural killer (NK) cells to NK cell stimulatory factor (NKSF): cytolytic activity and proliferation of NK cells is differentially regulated by NKSF. J. Exp. Med. 175:779.
31. Robertson, M. J., K. J. Cochran, C. Cameron, J.-M. Le, R. Tantravahi, and J. Ritz. 1996. Characterization of a cell line, NKL, derived from an aggressive human natural killer cell leukemia. Exp. Hematol. 24:406.
32. Robertson, M. J., M. A. Caligiuri, T. J. Manley, H. Levine, and J. Ritz. 1990. Human natural killer cell adhesion molecules: differential expression after activation and participation in cytolysis. J. Immunol. 145:3194.
33. Voss, S. D., P. M. Sondel, and R. J. Robb. 1992. Characterization of the interleukin 2 receptors (IL-2R) expressed on human natural killer cells activated in vivo by IL-2: association of p64 IL-2R γ chain with the IL-2R β chain in functional intermediate-affinity IL-2R. J. Exp. Med. 176:531.
34. Lazetic, S., C. Chang, J. P. Houchins, L. L. Lanier, and J. H. Phillips. 1996. Human natural killer cell receptors involved in MHC class I recognition are disulfide-linked heterodimers of CD94 and NKG2 subunits. J. Immunol. 157: 4741.
35. Brooks, A. G., P. E. Posch, C. J. Scorzelli, F. Borrego, and J. E. Coligan. 1997. NKG2A complexed with CD94 defines a novel inhibitory natural killer cell receptor. J. Exp. Med. 185:795.
36. Perez-Villar, J. J., M. Carretero, F. Navarro, I. Melero, A. Rodriguez, C. Bottino, J. Aramburu, A. Moretta, and M. Lopez-Botet. 1996. Biochemical and serologic evidence for the existence of functionally distinct forms of the CD94 NK cell receptor. J. Immunol. 157:5367.
37. + T lymphocytes. II. Modulation of natural killer cytotoxicity by anti-Kp 43 monoclonal antibody. J. Immunol. 147:714.
38. Perez-Villar, J. J., I. Melero, A. Rodriguez, M. Carretero, J. Aramburu, S. Sivori, A. M. Orengo, A. Moretta, and M. Lopez-Botet. 1995. Functional ambivalence of the Kp43 (CD94) NK cell-associated surface antigen. J. Immunol. 154:5779.
39. Azzoni, L., I. Anegon, B. Calabretta, and B. Perussia. 1995. Ligand binding to FcγR induces c-myc-dependent apoptosis in IL-2-stimulated NK cells. J. Immunol. 154:491.
40. Ortaldo, J. R., A. T. Mason, and J. J. O'Shea. 1995. Receptor-induced death in human natural killer cells: involvement of CD16. J. Exp. Med. 181:339.
41. Ida, H., M. J. Robertson, S. Voss, J. Ritz, and P. Anderson. 1997. CD94 ligation induces apoptosis in a subset of IL-2-activated NK cells. J. Immunol. 159:2154.
42. Burshtyn, D. N., A. M. Scharenberg, N. Wagtmann, S. Rajagopalan, K. Berrada, T. Yi, J.-P. Kinet, and E. O. Long. 1996. Recruitment of tyrosine phosphatase HCP by the killer cell inhibitory receptor. Immunity 4:77.
43. Olcese, L., P. Lang, F. Vely, A. Cambiaggi, D. Marguet, M. Blery, K. L. Hippen, R. Biassoni, A. Moretta, L. Moretta, J. C. Cambier, and E. Vivier. 1996. Human and mouse killer-cell inhibitory receptors recruit PTP1C and PTP1D protein tyrosine phosphatases. J. Immunol. 156:4531.
44. Fry, A. M., L. L. Lanier, and A. Weiss. 1996. Phosphotyrosines in killer cell inhibitory receptor motif of NKB1 are required for negative signaling and for association with protein tyrosine phosphatase 1C. J. Exp. Med. 184:295.
45. Pende, D., R. Biassoni, C. Cantoni, S. Verdiani, M. Falco, C. DiDinato, L. Accame, C. Bottino, A. Moretta, and L. Moretta. 1996. The natural killer cell receptor specific for HLA-A allotypes: a novel member of the p58/p70 family of inhibitory receptors that is characterized by three immunoglobulin-like domains and is expressed as a 140-kD disulphide-linked dimer. J. Exp. Med. 184:505.
46. Moretta, A., S. Sivori, M. Vitale, D. Pende, L. Morelli, R. Augugliaro, C. Bottino, and L. Moretta. 1995. Existence of both inhibitory (p58) and activatory (p50) receptors for HLA-C molecules in human natural killer cells. J. Exp. Med. 182: 875.
47. Biassoni, R., C. Cantoni, M. Falco, S. Verdiani, C. Bottino, M. Vitale, R. Conte, A. Poggi, A. Moretta, and L. Moretta. 1996. The human leukocyte antigen (HLA)-C-specific "activatory" or "inhibitory" natural killer cell receptors display highly homologous extracellular domains but differ in their transmembrane and intracytoplasmic portions. J. Exp. Med. 183:645.
48. Moretta, A., M. Vitale, S. Sivori, C. Bottino, L. Morelli, R. Augugliaro, M. Barbaresi, D. Pende, E. Ciccone, M. Lopez-Botet, and L. Moretta. 1994. Human natural killer cell receptors for HLA-class I molecules: evidence that the Kp43 (CD94) molecule functions as receptor for HLA-B alleles. J. Exp. Med. 180:545.
49. Phillips, J. H., C. Chang, J. Mattson, J. E. Gumperz, P. Parham, and L. L. Lanier. 1996. CD94 and a novel associated protein (94AP) form a NK cell receptor involved in the recognition of HLA-A, HLA-B, and HLA-C allotypes. Immunity 5:163.
50. Brumbaugh, K. M., J. J. Perez-Villar, C. J. Dick, R. A. Schoon, M. Lopez-Botet, and P. J. Leibson. 1996. Clonotypic differences in signaling from CD94 (kp43) on NK cells lead to divergent cellular responses. J. Immunol. 157:2804.
51. Leclerq, G., V. Debacker, M. DeSmedt, and J. Plum. 1996. Differential effects of interleukin-15 and interleukin-2 on differentiation of bipotential T/natural killer progenitor cells. J. Exp. Med. 184:325.
52. + hematopoietic progenitor cells. Blood 87:2632.
53. Bottino, C., S. Sivori, M. Vitale, C. Cantoni, M. Falco, D. Pende, L. Morelli, R. Augugliaro, G. Semenzato, R. Biassoni, L. Moretta, and A. Moretta. 1996. A novel surface molecule homologous to the p58/p50 family of receptors is selectively expressed on a subset of human natural killer cells and induces both triggering of cell functions and proliferation. Eur. J. Immunol. 26:1816.
54. Chang, C., A. Rodriguez, M. Carretero, M. Lopez-Botet, J. H. Phillips, and L. L. Lanier. 1995. Molecular characterization of human CD94: a type II membrane glycoprotein related to the C-type lectin superfamily. Eur. J. Immunol. 25:2433.
55. Houchins, J. P., T. Yabe, C. McSherry, and F. H. Bach. 1991. DNA sequence analysis of NKG2, a family of related cDNA clones encoding type II integral membrane proteins on human natural killer cells. J. Exp. Med. 173:1017.
56. Houchins, J. P., L. L. Lanier, E. C. Niemi, J. H. Phillips, and J. C. Ryan. 1997. Natural killer cell cytolytic activity is inhibited by NKG2-A and activated by NKG2-C. J. Immunol. 158:3603.